FORM | |
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) | |
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (IRS Employer Identification Number) | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
(d) | Exhibits | |
Exhibit 23 Consent of Independent Registered Public Accounting Firm* | ||
Exhibit 99.1 Item 1: Business* | ||
Exhibit 99.2 Item 2: Properties* | ||
Exhibit 99.3 Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations* | ||
Exhibit 99.4 Item 8: Financial Statements and Supplementary Data* | ||
* filed herewith | ||
NORTHROP GRUMMAN CORPORATION | ||||||
(Registrant) | ||||||
By: | /s/ Jennifer C. McGarey | |||||
(Signature) Jennifer C. McGarey Corporate Vice President and Secretary | ||||||
Exhibit No. |
Exhibit 101 — Northrop Grumman Corporation Current Report on Form 8-K dated April 29, 2020, formatted in XBRL (Extensible Business Reporting Language): Cover Page. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Exhibit 104 — Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
$ in millions | U.S. Government(1) | International(2) | Other Customers | Total | Percentage of Total Sales | ||||||||||||||
Cost-type contracts | $ | 15,720 | $ | 683 | $ | 76 | $ | 16,479 | 49 | % | |||||||||
Fixed-price contracts | 12,214 | 4,471 | 677 | 17,362 | 51 | % | |||||||||||||
Total sales | $ | 27,934 | $ | 5,154 | $ | 753 | $ | 33,841 | 100 | % | |||||||||
(1) | Sales to the U.S. government include sales from contracts for which we are the prime contractor, as well as those for which we are a subcontractor and the ultimate customer is the U.S. government. Each of the company’s segments derives substantial revenue from the U.S. government. |
Square feet (in thousands) | Owned | Leased | U.S. Government Owned/Leased | Total | ||||||||
Aeronautics Systems | 3,415 | 6,153 | 3,255 | 12,823 | ||||||||
Defense Systems | 1,364 | 4,685 | 4,767 | 10,816 | ||||||||
Mission Systems | 7,935 | 4,468 | — | 12,403 | ||||||||
Space Systems | 9,349 | 6,662 | 621 | 16,632 | ||||||||
Corporate | 614 | 492 | — | 1,106 | ||||||||
Total | 22,677 | 22,460 | 8,643 | 53,780 | ||||||||
• | our dependence on the U.S. government for a substantial portion of our business |
• | significant delays or reductions in appropriations for our programs, and U.S. government funding and program support more broadly |
• | investigations, claims, disputes, enforcement actions, litigation and/or other legal proceedings |
• | the use of estimates when accounting for our contracts and the effect of contract cost growth and/or changes in estimated contract revenues and costs |
• | our exposure to additional risks as a result of our international business, including risks related to geopolitical and economic factors, suppliers, laws and regulations |
• | the improper conduct of employees, agents, subcontractors, suppliers, business partners or joint ventures in which we participate and the impact on our reputation and our ability to do business |
• | cyber and other security threats or disruptions faced by us, our customers or our suppliers and other partners |
• | the performance and financial viability of our subcontractors and suppliers and the availability and pricing of raw materials and components |
• | changes in procurement and other laws, regulations, contract terms and practices applicable to our industry, findings by the U.S. government as to our compliance with such requirements, and changes in our customers’ business practices globally |
• | increased competition within our markets and bid protests |
• | the ability to maintain a qualified workforce with the required security clearances and requisite skills |
• | our ability to meet performance obligations under our contracts, including obligations that require innovative design capabilities, are technologically complex, require certain manufacturing expertise or are dependent on factors not wholly within our control |
• | environmental matters, including unforeseen environmental costs and government and third party claims |
• | natural disasters |
• | the adequacy and availability of our insurance coverage, customer indemnifications or other liability protections |
• | products and services we provide related to hazardous and high risk operations, including the production and use of such products, which subject us to various environmental, regulatory, financial, reputational and other risks |
• | the future investment performance of plan assets, changes in actuarial assumptions associated with our pension and other postretirement benefit plans and legislative or other regulatory actions impacting our pension and postretirement benefit obligations |
• | our ability appropriately to exploit and/or protect intellectual property rights |
• | our ability to develop new products and technologies and maintain technologies, facilities, and equipment to win new competitions and meet the needs of our customers |
• | unanticipated changes in our tax provisions or exposure to additional tax liabilities |
• | changes in business conditions that could impact business investments and/or recorded goodwill or the value of other long-lived assets |
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions, except per share amounts | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Sales | $ | 33,841 | $ | 30,095 | $ | 26,004 | 12 | % | 16 | % | |||||||
Operating costs and expenses | 29,872 | 26,315 | 22,786 | 14 | % | 15 | % | ||||||||||
Operating costs and expenses as a % of sales | 88.3 | % | 87.4 | % | 87.6 | % | |||||||||||
Operating income | 3,969 | 3,780 | 3,218 | 5 | % | 17 | % | ||||||||||
Operating margin rate | 11.7 | % | 12.6 | % | 12.4 | % | |||||||||||
Mark-to-market pension and OPB (expense) benefit | (1,800 | ) | (655 | ) | 536 | 175 | % | NM | |||||||||
Federal and foreign income tax expense | 300 | 513 | 1,360 | (42 | )% | (62 | )% | ||||||||||
Effective income tax rate | 11.8 | % | 13.7 | % | 32.2 | % | |||||||||||
Net earnings | 2,248 | 3,229 | 2,869 | (30 | )% | 13 | % | ||||||||||
Diluted earnings per share | 13.22 | 18.49 | 16.34 | (29 | )% | 13 | % | ||||||||||
Year Ended December 31 | |||||||||||
$ in millions | 2019 | 2018 | 2017 | ||||||||
Actuarial (losses) gains on projected benefit obligation | $ | (4,866 | ) | $ | 2,772 | $ | (1,570 | ) | |||
Actuarial gains (losses) on plan assets | 3,066 | (3,426 | ) | 2,119 | |||||||
Other | — | (1 | ) | (13 | ) | ||||||
MTM (expense) benefit | $ | (1,800 | ) | $ | (655 | ) | $ | 536 | |||
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Net earnings | $ | 2,248 | $ | 3,229 | $ | 2,869 | (30 | )% | 13 | % | |||||||
MTM expense (benefit) | 1,800 | 655 | (536 | ) | 175 | % | NM | ||||||||||
MTM-related deferred state tax (benefit) expense(1) | (81 | ) | (29 | ) | 24 | 179 | % | NM | |||||||||
Federal tax (benefit) expense of items above(2) | (361 | ) | (131 | ) | 108 | 176 | % | NM | |||||||||
MTM expense (benefit), net of tax | 1,358 | 495 | (404 | ) | 174 | % | NM | ||||||||||
MTM-adjusted net earnings | $ | 3,606 | $ | 3,724 | $ | 2,465 | (3 | )% | 51 | % | |||||||
(1) | Deferred state taxes are recorded in unallocated corporate expense within operating income. |
(2) | Based on a 21% federal statutory tax rate. |
Year Ended December 31 | % Change in | ||||||||||||||||
2019 | 2018 | 2017 | 2019 | 2018 | |||||||||||||
Diluted earnings per share | $ | 13.22 | $ | 18.49 | $ | 16.34 | (29 | )% | 13 | % | |||||||
MTM expense (benefit) per share | 10.59 | 3.76 | (3.06 | ) | 182 | % | NM | ||||||||||
MTM-related deferred state tax (benefit) expense per share(1) | (0.48 | ) | (0.17 | ) | 0.14 | 182 | % | NM | |||||||||
Federal tax (benefit) expense of items above per share(2) | (2.12 | ) | (0.75 | ) | 0.62 | 183 | % | NM | |||||||||
MTM expense (benefit) per share, net of tax | 7.99 | 2.84 | (2.30 | ) | 181 | % | NM | ||||||||||
MTM-adjusted diluted earnings per share | $ | 21.21 | $ | 21.33 | $ | 14.04 | (1 | )% | 52 | % | |||||||
(1) | Deferred state taxes are recorded in unallocated corporate expense within operating income. |
(2) | Based on a 21% federal statutory tax rate. |
Aeronautics Systems | Defense Systems | Mission Systems | Space Systems | |||
Autonomous Systems | Battle Management & Missile Systems | Airborne Sensors & Networks | Launch & Strategic Missiles | |||
Manned Aircraft | Mission Readiness | Cyber & Intelligence Mission Solutions | Space | |||
Maritime/Land Systems & Sensors | ||||||
Navigation, Targeting & Survivability | ||||||
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Segment operating income | $ | 3,909 | $ | 3,447 | $ | 2,903 | 13 | % | 19 | % | |||||||
Segment operating margin rate | 11.6 | % | 11.5 | % | 11.2 | % | |||||||||||
CAS pension expense | 832 | 1,017 | 1,026 | (18 | )% | (1 | )% | ||||||||||
Less: FAS (service) pension expense | (367 | ) | (404 | ) | (388 | ) | (9 | )% | 4 | % | |||||||
Net FAS (service)/CAS pension adjustment | 465 | 613 | 638 | (24 | )% | (4 | )% | ||||||||||
Intangible asset amortization and PP&E step-up depreciation | (390 | ) | (220 | ) | — | NM | NM | ||||||||||
MTM-related deferred state tax benefit (expense)(1) | 81 | 29 | (24 | ) | 179 | % | NM | ||||||||||
Other unallocated corporate expense | (96 | ) | (89 | ) | (299 | ) | 8 | % | (70 | )% | |||||||
Unallocated corporate expense | (405 | ) | (280 | ) | (323 | ) | 45 | % | (13 | )% | |||||||
Total operating income | $ | 3,969 | $ | 3,780 | $ | 3,218 | 5 | % | 17 | % | |||||||
(1) | Represents the deferred state tax impact of MTM (expense) benefit, which is recorded in unallocated corporate expense consistent with other changes in deferred state taxes. |
Year Ended December 31 | |||||||||||
$ in millions | 2019 | 2018 | 2017 | ||||||||
Favorable EAC adjustments | $ | 1,040 | $ | 1,019 | $ | 717 | |||||
Unfavorable EAC adjustments | (560 | ) | (442 | ) | (357 | ) | |||||
Net EAC adjustments | $ | 480 | $ | 577 | $ | 360 | |||||
Year Ended December 31 | |||||||||||
$ in millions | 2019 | 2018 | 2017 | ||||||||
Aeronautics Systems(1) | $ | 143 | $ | 271 | $ | 113 | |||||
Defense Systems(1) | 99 | 75 | 17 | ||||||||
Mission Systems | 189 | 172 | 89 | ||||||||
Space Systems(1) | 63 | 73 | 154 | ||||||||
Eliminations | (14 | ) | (14 | ) | (13 | ) | |||||
Net EAC adjustments | $ | 480 | $ | 577 | $ | 360 | |||||
(1) | Amounts reflect EAC adjustments after the percent complete on legacy Innovation Systems contracts was reset to zero as of the Merger date. |
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Sales | $ | 11,116 | $ | 10,293 | $ | 9,040 | 8 | % | 14 | % | |||||||
Operating income | 1,170 | 1,107 | 848 | 6 | % | 31 | % | ||||||||||
Operating margin rate | 10.5 | % | 10.8 | % | 9.4 | % | |||||||||||
Year Ended December 31 | % Change in | |||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | |||||||||||
Sales | $ | 7,495 | $ | 6,612 | 5,479 | 13 | % | 21 | % | |||||||
Operating income | 781 | 690 | 534 | 13 | % | 29 | % | |||||||||
Operating margin rate | 10.4 | % | 10.4 | % | 9.7 | % | ||||||||||
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Sales | $ | 9,410 | $ | 8,949 | $ | 8,460 | 5 | % | 6 | % | |||||||
Operating income | 1,382 | 1,215 | 1,157 | 14 | % | 5 | % | ||||||||||
Operating margin rate | 14.7 | % | 13.6 | % | 13.7 | % | |||||||||||
Year Ended December 31 | % Change in | ||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | ||||||||||||
Sales | $ | 7,425 | $ | 5,845 | $ | 4,719 | 27 | % | 24 | % | |||||||
Operating income | 781 | 635 | 578 | 23 | % | 10 | % | ||||||||||
Operating margin rate | 10.5 | % | 10.9 | % | 12.2 | % | |||||||||||
Year Ended December 31 | ||||||||||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||||||||||||||
Segment Information: | Sales | Operating Costs and Expenses | Sales | Operating Costs and Expenses | Sales | Operating Costs and Expenses | ||||||||||||||||||
Aeronautics Systems | ||||||||||||||||||||||||
Product | $ | 9,387 | $ | 8,444 | $ | 8,665 | $ | 7,749 | $ | 7,388 | $ | 6,715 | ||||||||||||
Service | 1,626 | 1,409 | 1,555 | 1,372 | 1,606 | 1,436 | ||||||||||||||||||
Intersegment eliminations | 103 | 93 | 73 | 65 | 46 | 41 | ||||||||||||||||||
Total Aeronautics Systems | 11,116 | 9,946 | 10,293 | 9,186 | 9,040 | 8,192 | ||||||||||||||||||
Defense Systems | ||||||||||||||||||||||||
Product | 2,784 | 2,577 | 1,703 | 1,523 | 370 | 323 | ||||||||||||||||||
Service | 4,020 | 3,520 | 4,159 | 3,723 | 4,135 | 3,745 | ||||||||||||||||||
Intersegment eliminations | 691 | 617 | 750 | 676 | 974 | 877 | ||||||||||||||||||
Total Defense Systems | 7,495 | 6,714 | 6,612 | 5,922 | 5,479 | 4,945 | ||||||||||||||||||
Mission Systems | ||||||||||||||||||||||||
Product | 6,022 | 5,091 | 5,790 | 5,013 | 5,388 | 4,642 | ||||||||||||||||||
Service | 2,660 | 2,322 | 2,441 | 2,118 | 2,434 | 2,129 | ||||||||||||||||||
Intersegment eliminations | 728 | 615 | 718 | 603 | 638 | 532 | ||||||||||||||||||
Total Mission Systems | 9,410 | 8,028 | 8,949 | 7,734 | 8,460 | 7,303 | ||||||||||||||||||
Space Systems | ||||||||||||||||||||||||
Product | 5,659 | 5,031 | 4,311 | 3,805 | 3,218 | 2,784 | ||||||||||||||||||
Service | 1,683 | 1,538 | 1,471 | 1,345 | 1,465 | 1,327 | ||||||||||||||||||
Intersegment eliminations | 83 | 75 | 63 | 60 | 36 | 30 | ||||||||||||||||||
Total Space Systems | 7,425 | 6,644 | 5,845 | 5,210 | 4,719 | 4,141 | ||||||||||||||||||
Segment Totals | ||||||||||||||||||||||||
Total Product | $ | 23,852 | $ | 21,143 | $ | 20,469 | $ | 18,090 | $ | 16,364 | $ | 14,464 | ||||||||||||
Total Service | 9,989 | 8,789 | 9,626 | 8,558 | 9,640 | 8,637 | ||||||||||||||||||
Total Segment(1) | $ | 33,841 | $ | 29,932 | $ | 30,095 | $ | 26,648 | $ | 26,004 | $ | 23,101 | ||||||||||||
(1) | A reconciliation of segment operating income to total operating income is included in “Segment Operating Results.” |
2019 | 2018 | ||||||||||||||||||
$ in millions | Funded | Unfunded | Total Backlog | Total Backlog | % Change in 2019 | ||||||||||||||
Aeronautics Systems | $ | 10,454 | $ | 15,567 | $ | 26,021 | $ | 20,991 | 24 | % | |||||||||
Defense Systems | 6,443 | 2,038 | 8,481 | 7,181 | 18 | % | |||||||||||||
Mission Systems | 9,032 | 5,194 | 14,226 | 12,069 | 18 | % | |||||||||||||
Space Systems | 4,348 | 11,764 | 16,112 | 13,259 | 22 | % | |||||||||||||
Total backlog | $ | 30,277 | $ | 34,563 | $ | 64,840 | $ | 53,500 | 21 | % | |||||||||
Year Ended December 31 | ||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||
Net earnings | $ | 2,248 | $ | 3,229 | $ | 2,869 | ||||||
Non-cash items(1) | 2,683 | 1,775 | 1,018 | |||||||||
Changes in assets and liabilities: | ||||||||||||
Trade working capital | 128 | (65 | ) | (285 | ) | |||||||
Retiree benefits, excluding MTM (expense) benefit | (703 | ) | (1,083 | ) | (946 | ) | ||||||
Other, net | (59 | ) | (29 | ) | (43 | ) | ||||||
Net cash provided by operating activities | $ | 4,297 | $ | 3,827 | $ | 2,613 | ||||||
(1) | Includes depreciation and amortization, MTM (expense) benefit, non-cash lease expense, stock based compensation expense and deferred income taxes. |
Year Ended December 31 | % Change in | |||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | |||||||||||||
Net cash provided by operating activities | $ | 4,297 | $ | 3,827 | $ | 2,613 | 12 | % | 46 | % | ||||||||
Less: capital expenditures | (1,264 | ) | (1,249 | ) | (928 | ) | 1 | % | 35 | % | ||||||||
Free cash flow | $ | 3,033 | $ | 2,578 | $ | 1,685 | 18 | % | 53 | % | ||||||||
$ in millions | Total | 2020 | 2021- 2022 | 2023- 2024 | 2025 and beyond | |||||||||||||||
Long-term debt | $ | 13,945 | $ | 1,110 | $ | 2,247 | $ | 1,056 | $ | 9,532 | ||||||||||
Interest payments on long-term debt | 6,632 | 524 | 956 | 830 | 4,322 | |||||||||||||||
Operating leases | 1,992 | 300 | 486 | 331 | 875 | |||||||||||||||
Purchase obligations(1) | 15,126 | 8,089 | 2,839 | 2,213 | 1,985 | |||||||||||||||
Other long-term liabilities(2) | 1,516 | 490 | 341 | 176 | 509 | |||||||||||||||
Total contractual obligations | $ | 39,211 | $ | 10,513 | $ | 6,869 | $ | 4,606 | $ | 17,223 | ||||||||||
(1) | A “purchase obligation” is defined as an agreement to purchase goods or services that is enforceable and legally binding on us and that specifies all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum, or variable price provisions; and the approximate timing of the transaction. These amounts are primarily comprised of open purchase order commitments to suppliers and subcontractors pertaining to funded contracts. |
(2) | Other long-term liabilities, including their current portions, primarily consist of total accrued environmental reserves, deferred compensation, and other miscellaneous liabilities. It excludes obligations for uncertain tax positions of $1.2 billion as we are not able to reasonably estimate the timing of future cash flows related to such positions. |
$ in millions | 25 Basis Point Decrease in Rate | 25 Basis Point Increase in Rate | |||||
2020 pension and OPB (benefit) expense | $ | (34 | ) | $ | 31 | ||
2019 pension and OPB obligation and MTM expense (benefit) | 1,297 | (1,230 | ) | ||||
$ in millions | 25 Basis Point Decrease in Rate | 25 Basis Point Increase in Rate | |||||
2020 pension (benefit) expense | $ | (11 | ) | $ | 12 | ||
2019 pension obligation and MTM expense (benefit) | (136 | ) | 151 | ||||
$ in millions | 25 Basis Point Decrease | 25 Basis Point Increase | |||||
2020 pension and OPB expense (benefit) | $ | 78 | $ | (78 | ) | ||
$ in millions | 100 Basis Point Decrease | 100 Basis Point Increase | |||||
2020 MTM expense (benefit) | $ | 312 | $ | (312 | ) | ||
• | We tested the effectiveness of controls over the estimates of total costs and revenues on such contracts, including development costs and any related award or incentive fee estimates for the relevant performance obligations. |
• | We selected certain long-term contracts for testing and performed the following procedures: |
– | Evaluated whether the recognition of revenue over time on such contracts was appropriate based on the terms and conditions of each contract, including whether continuous transfer of control to the customer occurred as progress was made toward fulfilling the performance obligation. |
– | Tested management’s identification of distinct performance obligations by evaluating whether the underlying goods and services were highly interdependent and interrelated. |
– | Tested management’s determination of the transaction price, including any award or incentive fees, based on the consideration expected to be received in accordance with the rights and obligations established under the contracts and any contractual modifications. |
– | Evaluated the estimates of total cost and revenue for the performance obligation by: |
▪ | Conducting site visits to the relevant program locations and directly observing the contract status, as well as making inquiries regarding any challenges related to the program. |
▪ | Comparing costs incurred to date to the costs management estimated to be incurred to date. |
▪ | Evaluating management’s ability to achieve the estimates of total cost and revenue by performing corroborating inquiries with the Company’s program and business management, and testing management’s process used to develop the estimates based on their work plans, engineering specifications, program labor, and supplier contracts. |
▪ | Comparing management’s estimates for the selected contracts to costs and revenues of similar performance obligations, when applicable. |
– | Tested the mathematical accuracy of management’s calculation of revenue recognized during the period for the performance obligations. |
• | We tested the effectiveness of internal controls relating to the identification and completeness of, and recognition for, uncertain tax positions, including management’s controls over the underlying key assumptions and inputs used to derive the estimates. |
• | With the assistance of our income tax specialists, we selected specific uncertain tax positions for testing and performed the following procedures: |
– | Performed inquiries of the Company’s tax department, financial reporting department, and other personnel directly involved in the development of the estimates. |
– | Obtained supporting documentation and evaluated how the Company supported the position, including the assumptions and estimates used for measurement, and how the taxing authorities have historically challenged the tax position, if applicable. |
– | Obtained and read opinions provided by external counsel, as applicable, regarding the tax position taken by the Company. |
– | Evaluated whether the uncertain tax position met the “more likely than not” recognition threshold. |
– | Evaluated the appropriateness and consistency of the methodologies and assumptions used by management when developing these estimates. |
• | We tested the mathematical accuracy of management’s calculations. |
/s/ | Deloitte & Touche LLP |
McLean, Virginia | |
January 29, 2020 | |
(April 28, 2020 as to the reclassification of segment information as described in Notes 1, 2, 8 and 16) | |
We have served as the Company’s auditor since 1975. | |
Year Ended December 31 | ||||||||||||
$ in millions, except per share amounts | 2019 | 2018 | 2017 | |||||||||
Sales | ||||||||||||
Product | $ | $ | $ | |||||||||
Service | ||||||||||||
Total sales | ||||||||||||
Operating costs and expenses | ||||||||||||
Product | ||||||||||||
Service | ||||||||||||
General and administrative expenses | ||||||||||||
Operating income | ||||||||||||
Other (expense) income | ||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ||||||
FAS (non-service) pension benefit | ||||||||||||
Mark-to-market pension and OPB (expense) benefit | ( | ) | ( | ) | ||||||||
Other, net | ||||||||||||
Earnings before income taxes | ||||||||||||
Federal and foreign income tax expense | ||||||||||||
Net earnings | $ | $ | $ | |||||||||
Basic earnings per share | $ | $ | $ | |||||||||
Weighted-average common shares outstanding, in millions | ||||||||||||
Diluted earnings per share | $ | $ | $ | |||||||||
Weighted-average diluted shares outstanding, in millions | ||||||||||||
Net earnings (from above) | $ | $ | $ | |||||||||
Other comprehensive loss | ||||||||||||
Change in unamortized prior service credit, net of tax expense of $15 in 2019, $19 in 2018 and $35 in 2017 | ( | ) | ( | ) | ( | ) | ||||||
Change in cumulative translation adjustment and other, net | ( | ) | ( | ) | ||||||||
Other comprehensive loss, net of tax | ( | ) | ( | ) | ( | ) | ||||||
Comprehensive income | $ | $ | $ | |||||||||
December 31 | ||||||||
$ in millions, except par value | 2019 | 2018 | ||||||
Assets | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Accounts receivable, net | ||||||||
Unbilled receivables, net | ||||||||
Inventoried costs, net | ||||||||
Prepaid expenses and other current assets | ||||||||
Total current assets | ||||||||
Property, plant and equipment, net of accumulated depreciation of $5,850 for 2019 and $5,369 for 2018 | ||||||||
Operating lease right-of-use assets | ||||||||
Goodwill | ||||||||
Intangible assets, net | ||||||||
Deferred tax assets | ||||||||
Other non-current assets | ||||||||
Total assets | $ | $ | ||||||
Liabilities | ||||||||
Trade accounts payable | $ | $ | ||||||
Accrued employee compensation | ||||||||
Advance payments and billings in excess of costs incurred | ||||||||
Other current liabilities | ||||||||
Total current liabilities | ||||||||
Long-term debt, net of current portion of $1,109 for 2019 and $517 for 2018 | ||||||||
Pension and other postretirement benefit plan liabilities | ||||||||
Operating lease liabilities | ||||||||
Deferred tax liabilities | ||||||||
Other non-current liabilities | ||||||||
Total liabilities | ||||||||
Commitments and contingencies (Note 12) | ||||||||
Shareholders’ equity | ||||||||
Preferred stock, $1 par value; 10,000,000 shares authorized; no shares issued and outstanding | ||||||||
Common stock, $1 par value; 800,000,000 shares authorized; issued and outstanding: 2019—167,848,424 and 2018—170,607,336 | ||||||||
Paid-in capital | ||||||||
Retained earnings | ||||||||
Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
Total shareholders’ equity | ||||||||
Total liabilities and shareholders’ equity | $ | $ | ||||||
Year Ended December 31 | ||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||
Operating activities | ||||||||||||
Net earnings | $ | $ | $ | |||||||||
Adjustments to reconcile to net cash provided by operating activities: | ||||||||||||
Depreciation and amortization | ||||||||||||
Mark-to-market pension and OPB expense (benefit) | ( | ) | ||||||||||
Non-cash lease expense | ||||||||||||
Stock-based compensation | ||||||||||||
Deferred income taxes | ( | ) | ||||||||||
Changes in assets and liabilities: | ||||||||||||
Accounts receivable, net | ( | ) | ||||||||||
Unbilled receivables, net | ( | ) | ( | ) | ( | ) | ||||||
Inventoried costs, net | ( | ) | ( | ) | ||||||||
Prepaid expenses and other assets | ( | ) | ( | ) | ( | ) | ||||||
Accounts payable and other liabilities | ||||||||||||
Income taxes payable, net | ( | ) | ( | ) | ( | ) | ||||||
Retiree benefits | ( | ) | ( | ) | ( | ) | ||||||
Other, net | ( | ) | ( | ) | ( | ) | ||||||
Net cash provided by operating activities | ||||||||||||
Investing activities | ||||||||||||
Acquisition of Orbital ATK, net of cash acquired | ( | ) | ||||||||||
Capital expenditures | ( | ) | ( | ) | ( | ) | ||||||
Other, net | ||||||||||||
Net cash used in investing activities | ( | ) | ( | ) | ( | ) | ||||||
Financing activities | ||||||||||||
Payments of long-term debt | ( | ) | ( | ) | ||||||||
Net proceeds from issuance of long-term debt | ||||||||||||
Payments to credit facilities | ( | ) | ( | ) | ( | ) | ||||||
Net (repayments of) borrowings on commercial paper | ( | ) | ||||||||||
Common stock repurchases | ( | ) | ( | ) | ( | ) | ||||||
Cash dividends paid | ( | ) | ( | ) | ( | ) | ||||||
Payments of employee taxes withheld from share-based awards | ( | ) | ( | ) | ( | ) | ||||||
Other, net | ( | ) | ( | ) | ( | ) | ||||||
Net cash (used in) provided by financing activities | ( | ) | ( | ) | ||||||||
Increase (decrease) in cash and cash equivalents | ( | ) | ||||||||||
Cash and cash equivalents, beginning of year | ||||||||||||
Cash and cash equivalents, end of year | $ | $ | $ | |||||||||
Year Ended December 31 | ||||||||||||
$ in millions, except per share amounts | 2019 | 2018 | 2017 | |||||||||
Common stock | ||||||||||||
Beginning of year | $ | $ | $ | |||||||||
Common stock repurchased | ( | ) | ( | ) | ( | ) | ||||||
Shares issued for employee stock awards and options | ||||||||||||
End of year | ||||||||||||
Paid-in capital | ||||||||||||
Beginning of year | ||||||||||||
Common stock repurchased | ( | ) | ||||||||||
Stock compensation | ( | ) | ||||||||||
End of year | ||||||||||||
Retained earnings | ||||||||||||
Beginning of year | ||||||||||||
Impact from adoption of ASU 2018-02 and ASU 2016-01 | ( | ) | ||||||||||
Common stock repurchased | ( | ) | ( | ) | ( | ) | ||||||
Net earnings | ||||||||||||
Dividends declared | ( | ) | ( | ) | ( | ) | ||||||
Stock compensation | ( | ) | ( | ) | ||||||||
End of year | ||||||||||||
Accumulated other comprehensive (loss) income | ||||||||||||
Beginning of year | ( | ) | ||||||||||
Impact from adoption of ASU 2018-02 and ASU 2016-01 | ||||||||||||
Other comprehensive income (loss), net of tax | ( | ) | ( | ) | ( | ) | ||||||
End of year | ( | ) | ( | ) | ||||||||
Total shareholders’ equity | $ | $ | $ | |||||||||
Cash dividends declared per share | $ | $ | $ | |||||||||
Year Ended December 31 | |||||||||||
$ in millions, except per share data | 2019 | 2018 | 2017 | ||||||||
Revenue | $ | $ | $ | ||||||||
Operating income | |||||||||||
Net earnings(1) | |||||||||||
Diluted earnings per share(1) | |||||||||||
(1) | Based on a 21% federal statutory tax rate for the years ended December 31, 2019 and 2018 and a 35% federal statutory tax rate for the year ended December 31, 2017. |
$ in millions | December 31, 2019 | December 31, 2018 | $ Change | % Change | ||||||||
Unbilled receivables, net | $ | $ | $ | % | ||||||||
Advance payments and amounts in excess of costs incurred | ( | ) | ( | ) | ( | ) | % | |||||
Net contract assets | $ | $ | $ | ( | ) | % | ||||||
December 31 | ||||||||||
Useful life in years, $ in millions | Useful Life | 2019 | 2018 | |||||||
Land and land improvements | Up to 40(1) | $ | $ | |||||||
Buildings and improvements | Up to 45 | |||||||||
Machinery and other equipment | Up to 20 | |||||||||
Capitalized software costs | 3-5 | |||||||||
Leasehold improvements | Length of Lease(2) | |||||||||
Property, plant and equipment, at cost | ||||||||||
Accumulated depreciation | ( | ) | ( | ) | ||||||
Property, plant and equipment, net | $ | $ | ||||||||
(1) | Land is not a depreciable asset. |
(2) | Leasehold improvements are depreciated over the shorter of the useful life of the asset or the length of the lease. |
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Unamortized prior service credit, net of tax expense of $17 for 2019 and $32 for 2018 | $ | $ | ||||||
Cumulative translation adjustment | ( | ) | ( | ) | ||||
Other, net | ( | ) | ( | ) | ||||
Total accumulated other comprehensive loss | $ | ( | ) | $ | ( | ) | ||
$ in millions, except per share amounts | Purchase price | |||
Shares of Orbital ATK common stock outstanding as of the Merger date | ||||
Cash consideration per share of Orbital ATK common stock | $ | |||
Total purchase price | $ | |||
$ in millions | As of June 6, 2018 | |||
Cash and cash equivalents | $ | |||
Accounts receivable | ||||
Unbilled receivables | ||||
Inventoried costs | ||||
Other current assets | ||||
Property, plant and equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other non-current assets | ||||
Total assets acquired | ||||
Trade accounts payable | ( | ) | ||
Accrued employee compensation | ( | ) | ||
Advance payments and billings in excess of costs incurred | ( | ) | ||
Below market contracts(1) | ( | ) | ||
Other current liabilities | ( | ) | ||
Long-term debt | ( | ) | ||
Pension and OPB plan liabilities | ( | ) | ||
Deferred tax liabilities | ( | ) | ||
Other non-current liabilities | ( | ) | ||
Total liabilities assumed | ( | ) | ||
Total purchase price | $ | |||
(1) | Included in Other current liabilities in the consolidated statements of financial position. |
Fair Value (in millions) | Estimated Useful Life in Years | |||||
Customer contracts | $ | |||||
Commercial customer relationships | ||||||
Total customer-related intangible assets | $ | |||||
Year Ended December 31 | |||||||||
$ in millions, except per share amounts | 2018 | 2017 | |||||||
Sales | $ | $ | |||||||
Net earnings | |||||||||
Diluted earnings per share | |||||||||
1. | The impact of the adoption of ASC Topic 606 on Orbital ATK’s historical sales of $ |
2. | The elimination of intercompany sales and costs of sales between the company and Orbital ATK of $ |
3. | The elimination of nonrecurring transaction costs incurred by the company and Orbital ATK in connection with the Merger of $ |
4. | The recognition of additional depreciation expense, net of removal of historical depreciation expense, of $ |
5. | Additional interest expense related to the debt issued to finance the Merger, including amortization of the debt issuance costs associated with the newly issued debt, of $ |
6. | The recognition of additional amortization expense, net of removal of historical amortization expense, of $ |
7. | The elimination of Orbital ATK’s historical amortization of net actuarial losses and prior service credits and impact of the revised pension and OPB net periodic benefit cost as determined under the company’s plan assumptions of $ |
8. | The income tax effect on the pro forma adjustments, which was calculated using the federal statutory tax rate in effect in each respective period, of $( |
Repurchase Program Authorization Date | Amount Authorized (in millions) | Total Shares Retired (in millions) | Average Price Per Share(1) | Date Completed | Shares Repurchased (in millions) | |||||||||||||||||
Year Ended December 31 | ||||||||||||||||||||||
2019 | 2018 | 2017 | ||||||||||||||||||||
September 16, 2015 | $ | $ | ||||||||||||||||||||
December 4, 2018 | $ | $ | ||||||||||||||||||||
(1) | Includes commissions paid. |
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Due from U.S. government (1) | $ | $ | ||||||
Due from international and other customers | ||||||||
Accounts receivable, gross | ||||||||
Allowance for doubtful accounts | ( | ) | ( | ) | ||||
Accounts receivable, net | $ | $ | ||||||
(1) | Includes receivables due from the U.S. government associated with foreign military sales (FMS). For FMS, we contract with and are paid by the U.S. government. |
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Due from U.S. government (1) | ||||||||
Unbilled receivables | $ | $ | ||||||
Progress and performance-based payments received | ( | ) | ( | ) | ||||
Total due from U.S. government | ||||||||
Due from international and other customers | ||||||||
Unbilled receivables | ||||||||
Progress and performance-based payments received | ( | ) | ( | ) | ||||
Total due from international and other customers | ||||||||
Unbilled receivables, net of progress and performance-based payments received | ||||||||
Allowance for doubtful accounts | ( | ) | ( | ) | ||||
Unbilled receivables, net | $ | $ | ||||||
(1) |
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Production costs of contracts in process | $ | $ | ||||||
G&A expenses | ||||||||
Progress and performance-based payments received | ( | ) | ( | ) | ||||
Product inventory and raw material | ||||||||
Inventoried costs, net | $ | $ | ||||||
Year Ended December 31 | ||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||
Federal income tax expense: | ||||||||||||
Current | $ | $ | $ | |||||||||
Deferred | ( | ) | ||||||||||
Total federal income tax expense | ||||||||||||
Foreign income tax expense: | ||||||||||||
Current | ||||||||||||
Deferred | ( | ) | ||||||||||
Total foreign income tax expense | ||||||||||||
Total federal and foreign income tax expense | $ | $ | $ | |||||||||
Year Ended December 31 | |||||||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | ||||||||||||||||||
Income tax expense at statutory rate | $ | % | $ | % | $ | % | |||||||||||||||
Stock compensation - excess tax benefits | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||
Research credit | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||
Foreign derived intangible income | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||
Manufacturing deduction | ( | ) | ( | ) | |||||||||||||||||
Settlements with taxing authorities | ( | ) | ( | ) | |||||||||||||||||
Impacts related to the 2017 Tax Act | ( | ) | ( | ) | |||||||||||||||||
MTM benefit tax rate differential(1) | ( | ) | ( | ) | |||||||||||||||||
Other, net | ( | ) | ( | ) | |||||||||||||||||
Total federal and foreign income taxes | $ | % | $ | % | $ | % | |||||||||||||||
(1) | Impact of applying the 2017 Tax Act enacted statutory tax rate of |
December 31 | ||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||
Unrecognized tax benefits at beginning of the year | $ | $ | $ | |||||||||
Additions based on tax positions related to the current year | ||||||||||||
Additions for tax positions of prior years | ||||||||||||
Reductions for tax positions of prior years | ( | ) | ( | ) | ( | ) | ||||||
Settlements with taxing authorities | ( | ) | ( | ) | ( | ) | ||||||
Other, net | ( | ) | ( | ) | ||||||||
Net change in unrecognized tax benefits | ||||||||||||
Unrecognized tax benefits at end of the year | $ | $ | $ | |||||||||
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Deferred Tax Assets | ||||||||
Retiree benefits | $ | $ | ||||||
Accrued employee compensation | ||||||||
Provisions for accrued liabilities | ||||||||
Inventory | ||||||||
Stock-based compensation | ||||||||
Operating lease liabilities | ||||||||
Tax credits | ||||||||
Other | ||||||||
Gross deferred tax assets | ||||||||
Less valuation allowance | ( | ) | ( | ) | ||||
Net deferred tax assets | ||||||||
Deferred Tax Liabilities | ||||||||
Goodwill | ||||||||
Purchased intangibles | ||||||||
Property, plant and equipment, net | ||||||||
Operating lease right-of-use assets | ||||||||
Contract accounting differences | ||||||||
Other | ||||||||
Deferred tax liabilities | ||||||||
Total net deferred tax assets (liabilities) | $ | $ | ( | ) | ||||
$ in millions | Aeronautics Systems | Defense Systems | Mission Systems | Space Systems | Total | |||||||||||||||
Balance as of December 31, 2017 | $ | $ | $ | $ | $ | |||||||||||||||
Acquisition of Orbital ATK | ||||||||||||||||||||
Other(1) | ( | ) | ( | ) | ||||||||||||||||
Balance as of December 31, 2018 | $ | $ | $ | $ | $ | |||||||||||||||
Acquisition of Orbital ATK | ||||||||||||||||||||
Other(1) | ( | ) | ( | ) | ||||||||||||||||
Balance as of December 31, 2019 | $ | $ | $ | $ | $ | |||||||||||||||
(1) |
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Gross customer-related and other intangible assets | $ | $ | ||||||
Less accumulated amortization | ( | ) | ( | ) | ||||
Net customer-related and other intangible assets | $ | $ | ||||||
$ in millions | ||||
2020 | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
December 31, 2019 | December 31, 2018 | |||||||||||||||||||||||
$ in millions | Level 1 | Level 2 | Total | Level 1 | Level 2 | Total | ||||||||||||||||||
Financial Assets (Liabilities) | ||||||||||||||||||||||||
Marketable securities | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Marketable securities valued using NAV | ||||||||||||||||||||||||
Total marketable securities | ||||||||||||||||||||||||
Derivatives | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
$ in millions | December 31 | |||||||||
2019 | 2018 | |||||||||
Fixed-rate notes and debentures, maturing in | Interest rate | |||||||||
2019 | $ | $ | ||||||||
2020 | ||||||||||
2021 | ||||||||||
2022 | ||||||||||
2023 | ||||||||||
2025 | ||||||||||
2026 | 7.75% - 7.88% | |||||||||
2027 | ||||||||||
2028 | ||||||||||
2031 | ||||||||||
2040 | ||||||||||
2043 | ||||||||||
2045 | ||||||||||
2047 | ||||||||||
Credit facilities | ||||||||||
Other | Various | |||||||||
Debt issuance costs | ( | ) | ( | ) | ||||||
Total long-term debt | ||||||||||
Less: current portion(1) | ||||||||||
Long-term debt, net of current portion | $ | $ | ||||||||
$ in millions | |||
Year Ending December 31 | |||
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
Thereafter | |||
Total principal payments | |||
Unamortized premium on long-term debt, net of discount | ( | ) | |
Debt issuance costs | ( | ) | |
Total long-term debt | $ | ||
$ in millions | Accrued Costs(1)(2) | Reasonably Possible Future Costs in excess of Accrued Costs(2) | Deferred Costs(3) | |||||||||
December 31, 2019 | $ | $ | $ | |||||||||
December 31, 2018 | ||||||||||||
(1) | As of December 31, 2019, $ |
(2) | Estimated remediation costs are not discounted to present value. The range of reasonably possible future costs does not take into consideration amounts expected to be recoverable through overhead charges on U.S. government contracts. |
(3) | As of December 31, 2019, $ |
Year Ended December 31 | ||||||||||||||||||||||||
Pension Benefits | Medical and Life Benefits | |||||||||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | 2017 | ||||||||||||||||||
Components of net periodic benefit cost (benefit) | ||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Interest cost | ||||||||||||||||||||||||
Expected return on plan assets | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Amortization of prior service credit | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Mark-to-market expense (benefit) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Other | ( | ) | ||||||||||||||||||||||
Net periodic benefit cost (benefit) | $ | $ | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
$ in millions | Pension Benefits | Medical and Life Benefits | Total | |||||||||
Changes in unamortized prior service credit | ||||||||||||
Amortization of prior service credit | $ | $ | $ | |||||||||
Tax expense | ( | ) | ( | ) | ( | ) | ||||||
Change in unamortized prior service credit – 2017 | ||||||||||||
Amortization of prior service credit | ||||||||||||
Tax expense | ( | ) | ( | ) | ( | ) | ||||||
Change in unamortized prior service credit – 2018 | ||||||||||||
Amortization of prior service credit | ||||||||||||
Tax expense | ( | ) | ( | ) | ( | ) | ||||||
Change in unamortized prior service credit – 2019 | $ | $ | $ | |||||||||
Pension Benefits | Medical and Life Benefits | |||||||||||||||
$ in millions | 2019 | 2018 | 2019 | 2018 | ||||||||||||
Plan Assets | ||||||||||||||||
Fair value of plan assets at beginning of year | $ | $ | $ | $ | ||||||||||||
Net gain (loss) on plan assets | ( | ) | ( | ) | ||||||||||||
Employer contributions | ||||||||||||||||
Participant contributions | ||||||||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Acquired plan assets | ||||||||||||||||
Other | ( | ) | ||||||||||||||
Fair value of plan assets at end of year | ||||||||||||||||
Projected Benefit Obligation | ||||||||||||||||
Projected benefit obligation at beginning of year | ||||||||||||||||
Service cost | ||||||||||||||||
Interest cost | ||||||||||||||||
Participant contributions | ||||||||||||||||
Actuarial loss (gain) | ( | ) | ( | ) | ||||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Acquired benefit obligation | ||||||||||||||||
Other | ( | ) | ( | ) | ||||||||||||
Projected benefit obligation at end of year | ||||||||||||||||
Funded status | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Classification of amounts recognized in the consolidated statements of financial position | ||||||||||||||||
Non-current assets | $ | $ | $ | $ | ||||||||||||
Current liability | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Non-current liability | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Projected benefit obligation | $ | $ | ||||||
Accumulated benefit obligation | ||||||||
Fair value of plan assets | ||||||||
Pension Benefits | Medical and Life Benefits | |||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||
Assumptions used to determine benefit obligation at December 31 | ||||||||||||
Discount rate | % | % | % | % | ||||||||
Initial cash balance crediting rate assumed for the next year | % | % | ||||||||||
Rate to which the cash balance crediting rate is assumed to increase (the ultimate rate) | % | % | ||||||||||
Year that the cash balance crediting rate reaches the ultimate rate | ||||||||||||
Rate of compensation increase | % | % | ||||||||||
Initial health care cost trend rate assumed for the next year | % | % | ||||||||||
Rate to which the health care cost trend rate is assumed to decline (the ultimate trend rate) | % | % | ||||||||||
Year that the health care cost trend rate reaches the ultimate trend rate | ||||||||||||
Assumptions used to determine benefit cost for the year ended December 31 | ||||||||||||
Discount rate | % | % | % | % | ||||||||
Initial cash balance crediting rate assumed for the next year | % | % | ||||||||||
Rate to which the cash balance crediting rate is assumed to increase (the ultimate rate) | % | % | ||||||||||
Year that the cash balance crediting rate reaches the ultimate rate | ||||||||||||
Expected long-term return on plan assets | % | % | % | % | ||||||||
Rate of compensation increase | % | % | ||||||||||
Initial health care cost trend rate assumed for the next year | % | % | ||||||||||
Rate to which the health care cost trend rate is assumed to decline (the ultimate trend rate) | % | % | ||||||||||
Year that the health care cost trend rate reaches the ultimate trend rate | ||||||||||||
Asset Allocation Ranges | |||||
Cash and cash equivalents | 0% - 12% | ||||
Global public equities | 30% - 50% | ||||
Fixed-income securities | 20% - 40% | ||||
Alternative investments | 18% - 38% | ||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||
$ in millions | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||||
Asset category | ||||||||||||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||
U.S. equities | ||||||||||||||||||||||||||||||||
International equities | $ | $ | ||||||||||||||||||||||||||||||
Fixed-income securities | ||||||||||||||||||||||||||||||||
U.S. Treasuries | ||||||||||||||||||||||||||||||||
U.S. Government Agency | ||||||||||||||||||||||||||||||||
Non-U.S. Government | ||||||||||||||||||||||||||||||||
Corporate debt | ||||||||||||||||||||||||||||||||
Asset backed | ||||||||||||||||||||||||||||||||
High yield debt | ||||||||||||||||||||||||||||||||
Bank loans | ||||||||||||||||||||||||||||||||
Other assets | ( | ) | ||||||||||||||||||||||||||||||
Investments valued using NAV as a practical expedient | ||||||||||||||||||||||||||||||||
U.S. equities | ||||||||||||||||||||||||||||||||
International equities | ||||||||||||||||||||||||||||||||
Fixed-income funds | ||||||||||||||||||||||||||||||||
Hedge funds | ||||||||||||||||||||||||||||||||
Opportunistic investments | ||||||||||||||||||||||||||||||||
Private equity funds | ||||||||||||||||||||||||||||||||
Real estate funds | ||||||||||||||||||||||||||||||||
Fair value of plan assets at the end of the year | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
$ in millions | Pension Plans | Medical and Life Plans | Total | |||||||||
Year Ending December 31 | ||||||||||||
2020 | $ | $ | $ | |||||||||
2021 | ||||||||||||
2022 | ||||||||||||
2023 | ||||||||||||
2024 | ||||||||||||
2025 through 2029 | ||||||||||||
Stock Awards (in thousands) | Weighted- Average Grant Date Fair Value Per Share | Weighted- Average Remaining Contractual Term (in years) | |||||||
Outstanding at January 1, 2017 | $ | ||||||||
Granted | |||||||||
Vested | ( | ) | |||||||
Forfeited | ( | ) | |||||||
Outstanding at December 31, 2017 | $ | ||||||||
Granted | |||||||||
Vested | ( | ) | |||||||
Forfeited | ( | ) | |||||||
Outstanding at December 31, 2018 | $ | ||||||||
Granted | |||||||||
Vested | ( | ) | |||||||
Forfeited | ( | ) | |||||||
Outstanding at December 31, 2019 | $ | ||||||||
Year Ended December 31 | ||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||
Minimum aggregate payout amount | $ | $ | $ | |||||||
Maximum aggregate payout amount | ||||||||||
$ in millions | Year Ended December 31, 2019 | |||
Operating lease cost | $ | |||
Variable lease cost | ||||
Short-term lease cost | ||||
Total lease cost | $ | |||
$ in millions | December 31, 2019 | |||
Operating lease right-of-use assets | $ | |||
Other current liabilities | ||||
Operating lease liabilities | ||||
Total operating lease liabilities | $ | |||
$ in millions | Year Ended December 31, 2019 | |||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | |||
Right-of-use assets obtained in exchange for new lease liabilities | ||||
Weighted average remaining lease term | ||||
Weighted average discount rate | % | |||
$ in millions | ||||
Year Ending December 31 | ||||
2020 | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
Thereafter | ||||
Total lease payments | ||||
Less: imputed interest | ( | ) | ||
Present value of operating lease liabilities | $ | |||
$ in millions | |||
Year Ending December 31 | |||
2019 | $ | ||
2020 | |||
2021 | |||
2022 | |||
2023 | |||
Thereafter | |||
Total minimum lease payments | $ | ||
Year Ended December 31 | ||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||
Sales | ||||||||||||
Aeronautics Systems | $ | $ | $ | |||||||||
Defense Systems | ||||||||||||
Mission Systems | ||||||||||||
Space Systems | ||||||||||||
Intersegment eliminations | ( | ) | ( | ) | ( | ) | ||||||
Total sales | ||||||||||||
Operating income | ||||||||||||
Aeronautics Systems | ||||||||||||
Defense Systems | ||||||||||||
Mission Systems | ||||||||||||
Space Systems | ||||||||||||
Intersegment eliminations | ( | ) | ( | ) | ( | ) | ||||||
Total segment operating income | ||||||||||||
Net FAS (service)/CAS pension adjustment | ||||||||||||
Unallocated corporate expense | ( | ) | ( | ) | ( | ) | ||||||
Total operating income | $ | $ | $ | |||||||||
Sales by Customer Type | Year Ended December 31 | ||||||||||||||||
2019 | 2018 | 2017 | |||||||||||||||
$ in millions | $ | %(3) | $ | %(3) | $ | %(3) | |||||||||||
Aeronautics Systems | |||||||||||||||||
U.S. government (1) | $ | % | $ | % | $ | % | |||||||||||
International (2) | % | % | % | ||||||||||||||
Other customers | % | % | % | ||||||||||||||
Intersegment sales | % | % | % | ||||||||||||||
Aeronautics Systems sales | % | % | % | ||||||||||||||
Defense Systems | |||||||||||||||||
U.S. government (1) | % | % | % | ||||||||||||||
International (2) | % | % | % | ||||||||||||||
Other customers | % | % | % | ||||||||||||||
Intersegment sales | % | % | % | ||||||||||||||
Defense Systems sales | % | % | % | ||||||||||||||
Mission Systems | |||||||||||||||||
U.S. government (1) | % | % | % | ||||||||||||||
International (2) | % | % | % | ||||||||||||||
Other customers | % | % | % | ||||||||||||||
Intersegment sales | % | % | % | ||||||||||||||
Mission Systems sales | % | % | % | ||||||||||||||
Space Systems | |||||||||||||||||
U.S. government (1) | % | % | % | ||||||||||||||
International (2) | % | % | % | ||||||||||||||
Other customers | % | % | % | ||||||||||||||
Intersegment sales | % | % | % | ||||||||||||||
Space Systems sales | % | % | % | ||||||||||||||
Total | |||||||||||||||||
U.S. government (1) | % | % | % | ||||||||||||||
International (2) | % | % | % | ||||||||||||||
Other customers | % | % | % | ||||||||||||||
Total Sales | $ | % | $ | % | $ | % | |||||||||||
(1) | Sales to the U.S. government include sales from contracts for which we are the prime contractor, as well as those for which we are a subcontractor and the ultimate customer is the U.S. government. Each of the company’s segments derives substantial revenue from the U.S. government. |
Sales by Contract Type | Year Ended December 31 | ||||||||||||||||
2019 | 2018 | 2017 | |||||||||||||||
$ in millions | $ | %(1) | $ | %(1) | $ | %(1) | |||||||||||
Aeronautics Systems | |||||||||||||||||
Cost-type | $ | % | $ | % | $ | % | |||||||||||
Fixed-price | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Aeronautics Systems sales | |||||||||||||||||
Defense Systems | |||||||||||||||||
Cost-type | % | % | % | ||||||||||||||
Fixed-price | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Defense Systems sales | |||||||||||||||||
Mission Systems | |||||||||||||||||
Cost-type | % | % | % | ||||||||||||||
Fixed-price | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Mission Systems sales | |||||||||||||||||
Space Systems | |||||||||||||||||
Cost-type | % | % | % | ||||||||||||||
Fixed-price | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Space Systems sales | |||||||||||||||||
Total | |||||||||||||||||
Cost-type | % | % | % | ||||||||||||||
Fixed-price | % | % | % | ||||||||||||||
Total Sales | $ | $ | $ | ||||||||||||||
(1) |
Sales by Geographic Region | Year Ended December 31 | ||||||||||||||||
2019 | 2018 | 2017 | |||||||||||||||
$ in millions | $ | %(2) | $ | %(2) | $ | %(2) | |||||||||||
Aeronautics Systems | |||||||||||||||||
United States | $ | % | $ | % | $ | % | |||||||||||
Asia/Pacific | % | % | % | ||||||||||||||
All other (1) | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Aeronautics Systems sales | |||||||||||||||||
Defense Systems | |||||||||||||||||
United States | % | % | % | ||||||||||||||
Asia/Pacific | % | % | % | ||||||||||||||
All other (1) | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Defense Systems sales | |||||||||||||||||
Mission Systems | |||||||||||||||||
United States | % | % | % | ||||||||||||||
Asia/Pacific | % | % | % | ||||||||||||||
All other (1) | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Mission Systems sales | |||||||||||||||||
Space Systems | |||||||||||||||||
United States | % | % | % | ||||||||||||||
Asia/Pacific | % | % | % | ||||||||||||||
All other (1) | % | % | % | ||||||||||||||
Intersegment sales | |||||||||||||||||
Space Systems sales | |||||||||||||||||
Total | |||||||||||||||||
United States | % | % | % | ||||||||||||||
Asia/Pacific | % | % | % | ||||||||||||||
All other (1) | % | % | % | ||||||||||||||
Total Sales | $ | $ | $ | ||||||||||||||
(1) | All other is principally comprised of Europe and the Middle East. |
(2) |
Year Ended December 31 | ||||||||||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | |||||||||||||||||||||
Sales | Operating Income | Sales | Operating Income | Sales | Operating Income | |||||||||||||||||||
Intersegment sales and operating income | ||||||||||||||||||||||||
Aeronautics Systems | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Defense Systems | ||||||||||||||||||||||||
Mission Systems | ||||||||||||||||||||||||
Space Systems | ||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
December 31 | ||||||||
$ in millions | 2019 | 2018 | ||||||
Assets | ||||||||
Aeronautics Systems | $ | $ | ||||||
Defense Systems | ||||||||
Mission Systems | ||||||||
Space Systems | ||||||||
Corporate assets(1) | ||||||||
Total assets | $ | $ | ||||||
(1) | Corporate assets principally consist of cash and cash equivalents, refundable taxes, deferred tax assets, property, plant and equipment and marketable securities. |
Year Ended December 31 | ||||||||||||||||||||||||
$ in millions | 2019 | 2018 | 2017 | 2019 | 2018 | 2017 | ||||||||||||||||||
Capital Expenditures | Depreciation and Amortization(1) | |||||||||||||||||||||||
Aeronautics Systems | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Defense Systems | ||||||||||||||||||||||||
Mission Systems | ||||||||||||||||||||||||
Space Systems | ||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) | Beginning in 2018, corporate amounts include the amortization of purchased intangible assets and the additional depreciation expense related to the step-up in fair value of property, plant and equipment acquired through business combinations as they are not considered part of management’s evaluation of segment operating performance. |
2019 | ||||||||||||||||
In millions, except per share amounts | 1st Qtr | 2nd Qtr | 3rd Qtr | 4th Qtr | ||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||
Operating income | ||||||||||||||||
Net earnings (loss) | ( | ) | ||||||||||||||
Basic earnings (loss) per share | ( | ) | ||||||||||||||
Diluted earnings (loss) per share(1) | ( | ) | ||||||||||||||
Weighted-average common shares outstanding | ||||||||||||||||
Weighted-average diluted shares outstanding(1) | ||||||||||||||||
2018 | ||||||||||||||||
In millions, except per share amounts | 1st Qtr | 2nd Qtr | 3rd Qtr | 4th Qtr | ||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||
Operating income | ||||||||||||||||
Net earnings | ||||||||||||||||
Basic earnings per share | ||||||||||||||||
Diluted earnings per share | ||||||||||||||||
Weighted-average common shares outstanding | ||||||||||||||||
Weighted-average diluted shares outstanding | ||||||||||||||||
(1) |